Loading organizations...
RH Capital operates as an impact-first venture capital fund investing in early-stage startups focused on women's health. The firm strategically deploys capital to companies developing solutions across the healthcare spectrum, aiming to catalyze new approaches and enhance patient outcomes. It empowers promising enterprises poised for significant impact within this vital sector.
The fund was founded by women, emerging from an insight into historical underinvestment and disparities in women's healthcare. Its leadership deeply understands sector challenges, informing an investment thesis centered on driving meaningful progress. This origin underpins RH Capital’s commitment to backing ventures that promise transformative, equitable advancements.
RH Capital primarily supports early-stage innovators in women's health. The firm envisions a future where women's healthcare is more innovative, accessible, and equitable. Its mission is to achieve societal impact by backing ventures that fundamentally reshape women's health and improve health equity throughout the United States.
RH Capital has 2 tracked investments across 2 companies. The latest tracked deal is $14.0M Series A in Evvy in September 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 27, 2023 | Evvy | $14.0M Series A | Laura Sillman | Amboy Street Ventures, G9 Ventures, General Catalyst, Ingeborg Investments, Labcorp, Virtue |
| Sep 13, 2022 | AOA Dx | $7.0M Other Equity | AlleyCorp, Avestria Ventures, Olive Tree Capital, RH Capital, Tencent Holdings, The Helm | — |